St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
Status:
Completed
Trial end date:
2018-12-19
Target enrollment:
Participant gender:
Summary
This study is a randomized controlled trial (RCT) to assess the feasibility, tolerability,
and safety of using opioid receptor antagonists (naltrexone and nalmefene) to treat pain
among HIV-infected persons with heavy alcohol use and chronic pain.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Boston Medical Center
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)